IndiaTickerLatest filing: Press Release - Gland Pharma Limited
ObservedCompany dossier
Gland Pharma
NSE:GLAND · ISIN INE068V01023
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gland Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,384.1 Cr · PAT ₹204.7 Cr.
Exchange XBRLLatest ownership: promoter group 51.77% and public 48.23% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Press Release - Gland Pharma Limited
NSE · exchange filing
Observed
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
BSE · exchange filing
Observed
Source filing Copy of Newspaper Publication - Gland Pharma Limited
NSE · exchange filing
Observed
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,384.1 Cr
- Profit after tax
- ₹204.7 Cr
- EPS
- ₹12.42
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 51.77%
- Public
- 48.23%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL